Roth Capital Reduces Earnings Estimates for Fortress Biotech
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Research analysts at Roth Capital decreased their Q1 2025 EPS estimates for shares of Fortress Biotech in a research report issued on Wednesday, April 2nd. Roth Capital analyst J. Wittes now expects that the biopharmaceutical company will post earnings per share of ($0.44) for the quarter, down […]
Fortress Biotech, Inc. (NASDAQ:FBIO – Free Report) – Research analysts at Roth Capital decreased their Q1 2025 EPS estimates for shares of Fortress Biotech in a research report issued on Wednesday, April 2nd. Roth Capital analyst J. Wittes now expects that the biopharmaceutical company will post earnings per share of ($0.44) for the quarter, down […]
